PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2019-11-06

Date Title Company
06-Nov-2019 Tocagen to Report Third Quarter 2019 Financial Results and Business Updates on Tuesday, November 12 Tocagen Inc.
06-Nov-2019 Ardelyx Announces Presentation at Kidney Week 2019 Ardelyx
06-Nov-2019 Natera Reports Third Quarter 2019 Financial Results Natera, Inc.
06-Nov-2019 Evofem Biosciences Reports Third Quarter 2019 Financial Results and Provides Corporate Update Evofem Biosciences, Inc.
06-Nov-2019 BioMarin to Highlight Innovative Development Pipeline at R&D Day on November 14th BioMarin Pharmaceutical Inc.
06-Nov-2019 Nektar Therapeutics Reports Financial Results for the Third Quarter of 2019 Nektar Therapeutics
06-Nov-2019 MorphoSys to Present Data on Tafasitamab at ASH 2019 Meeting (news with additional features) MorphoSys AG
06-Nov-2019 Ardelyx Reports Third Quarter 2019 Financial Results and Recent Highlights Ardelyx
06-Nov-2019 Sierra Oncology Announces Proposed Public Offering of Convertible Preferred Stock and Warrants Sierra Oncology
06-Nov-2019 Protagonist Therapeutics Announces First Patient Dosed in a Phase 2 Study of Oral IL-23 Receptor Antagonist PTG-200 (JNJ-67864238) in the Treatment of Crohn's Disease Protagonist Therapeutics, Inc.
06-Nov-2019 Statement from Center for Drug Evaluation and Research Director Janet Woodcock. M.D., on the agency's efforts to protect patients through postmarket drug safety surveillance practices U.S. Food and Drug Administration
06-Nov-2019 AbbVie Announces Launch of Private Offering of Senior Unsecured Notes AbbVie
06-Nov-2019 Ryvu Therapeutics Announces Presentations on CDK8 Inhibitor SEL120 at the 61st ASH Annual Meeting Ryvu Therapeutics S.A.
06-Nov-2019 Avantor® and NIBRT Collaborate to Advance Bioprocessing by Addressing Downstream Bottlenecks in Monoclonal Antibodies (mAbs) Production Avantor
06-Nov-2019 DNA Script to Open U.S. Office in South San Francisco to Support Commercialization of the Company's Industry-Leading Enzymatic Synthesis Technology DNA Script
06-Nov-2019 EACS 2019: ViiV Healthcare to present 17 abstracts from its portfolio addressing the diverse needs of people living with HIV ViiV Healthcare
06-Nov-2019 Q BioMed Announces $7.5M Grant Benefiting its Preclinical Product Development Pipeline Q BioMed
06-Nov-2019 EACS 2019: ViiV Healthcare to present 17 abstracts from its portfolio addressing the diverse needs of people living with HIV ViiV Healthcare
06-Nov-2019 ADC Therapeutics Announces Presentations at 61st American Society of Hematology (ASH) Annual Meeting ADC Therapeutics SA
06-Nov-2019 Urania Therapeutics closes a €3.5M initial seed round Urania Therapeutics